Searched for
PFIZER MARKETING AGREEMENT
Pfizer weighs sweeter offer for Metsera after Judge blocks bid to halt Novo Nordisk’s $10 billion takeoverPfizer is increasing its offer for Metsera. This comes after a judge rejected Pfizer's attempt to stop rival Novo Nordisk's bid. Pfizer's d...- Pfizer, Novo Nordisk escalate bidding war for obesity drug developer MetseraA fierce bidding war is underway for Metsera, an obesity drug developer. Novo Nordisk has made a $10 billion offer, which Metsera considers...
- Pfizer sues Metsera, Novo Nordisk over rival obesity drug bidPfizer sued Metsera and Novo Nordisk, alleging Metsera breached its merger agreement by deeming Novo's $8.5 billion bid superior. Pfizer se...
- Pfizer shares zoom nearly 9% after marketing and supply agreement with Mylan PharmaceuticalsPfizer shares surged 8.6% to Rs 4,448.35 after announcing a marketing and supply agreement with Mylan Pharmaceuticals for Ativan and Pacita...
- Pfizer board approves marketing, supply pact with Mylan for two brandsPfizer Ltd's board has approved a five-year marketing and supply agreement with Mylan Pharmaceuticals for the brands Ativan and Pacitane, t...
- India may have to wait longer for Pfizer, GSK's Covid drugsLast month Pfizer had announced an agreement with the UN's Medicines Patent Pool (MPP) for licensing antiviral intellectual property to MPP...
- Pfizer to allow generic versions of its COVID-19 pill in 95 countriesThe voluntary licensing agreement between Pfizer and the MPP will allow the United Nations-backed group to grant sub-licenses to qualified ...
- Pfizer's coronavirus vaccine isn't expected to reach India anytime soon; US, UK first in lineThe extremely stringent temperature requirement for mRNA vaccines, which is what the Pfizer vaccine candidate is based on, will also make i...
- CCI approves GSK, Pfizer joint venture in consumer healthcareGSK had in December last year announced that it had reached an agreement with Pfizer to combine the two companies’ consumer healthcare busi...
- Pfizer to sell Thane plant to Vidhi Research for Rs 178-croreIn July, Pfizer announced that it will close its over 50-year old Thane plant from September 16, 2015, which was lying idle since 2013.
- Pfizer ends supply deal with Claris LifesciencesMultinational drug-maker Pfizer Inc has terminated its three-year old supply deal with Claris Lifesciences, immediately after a ban on the ...
- Ranbaxy Laboratories launches generic Cadeut in the American marketDrug firm Ranbaxy Laboratories on Tuesday launched a generic version of Caduet, used for treating cardio vascular diseases, in the US marke...
- Watson starts selling generic Lipitor in US, Ranbaxy mumUS-based Watson Pharmaceuticals said it has launched in US market the generic version of cholesterol lowering drug Lipitor following the ex...
- Companies to gain as Big Pharma goes genericFaced with losses once its blockbusters start losing patents, Big Pharma is now devising strategies to counter the impact.
- Pfizer deal shot in arm for BioconAs per the deal, Biocon will conduct clinical development and regulatory filings while Pfizer will get the exclusive rights to market these...
- Biocon seals Rs 1,550 cr pact with PfizerThe agreement includes the commercialisation of Biocon’s biosimilar versions of insulin and insulin analog products: recombinant human insu...
- Pfizer faces US probe, to pay $2.3 bnPfizer will pay $2.3 bn to settle a US investigation into illegal marketing of medicines, the largest agreement in such a case, and a subsi...
- Aurobindo surges 5% on bourses after deal with PfizerAurobindo pharma on Wednesday surged as much as five per cent on bourses, a day after the domestic drug maker entered into multiple agreeme...
- Ranbaxy, Pfizer settle Lipitor litigation worldwideRanbaxy has settled most of its patent disputes with Pfizer, allowing it to launch a generic version of Lipitor from November 30, 2011. Ran...
- Pfizer quashes Ranbaxy bid talks as 'rumours', shares soarWorld's biggest drugmaker Pfizer today termed as "rumours" talks about its interest in acquiring Indian pharma major Ranbaxy, even as share...
Load More
